A detailed history of Legato Capital Management LLC transactions in Ocular Therapeutix, Inc stock. As of the latest transaction made, Legato Capital Management LLC holds 149,515 shares of OCUL stock, worth $1.48 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares
149,515
Previous 149,515 -0.0%
Holding current value
$1.48 Million
Previous $1.02 Million 27.2%
% of portfolio
0.17%
Previous 0.14%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 16, 2024

BUY
$2.08 - $4.52 $310,991 - $675,807
149,515 New
149,515 $666,000
Q2 2023

Aug 17, 2023

BUY
$4.6 - $7.64 $535,389 - $889,211
116,389 New
116,389 $600,000

Others Institutions Holding OCUL

About OCULAR THERAPEUTIX, INC


  • Ticker OCUL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,966,896
  • Market Cap $764M
  • Description
  • Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...
More about OCUL
Track This Portfolio

Track Legato Capital Management LLC Portfolio

Follow Legato Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legato Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Legato Capital Management LLC with notifications on news.